526139 TRABI

Transgene Biotek Share Price

 

 

Start SIP in TRABI

Start SIP

Performance

  • Low
  • ₹3
  • High
  • ₹3
  • 52 Week Low
  • ₹3
  • 52 Week High
  • ₹8
  • Open Price₹3
  • Previous Close₹3
  • Volume79,754

Investment Returns

  • Over 1 Month -19.41%
  • Over 3 Month -20.9%
  • Over 6 Month -28.47%
  • Over 1 Year -60.97%

Smart Investing Starts Here Start SIP with Transgene Biotek for Steady Growth!

Invest Now

Transgene Biotek Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -14
  • PEG Ratio
  • 0
  • Market Cap Cr
  • 23
  • P/B Ratio
  • Average True Range
  • 0.36
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • -0.21
  • RSI
  • 33.95
  • MFI
  • 16.82

Transgene Biotek Financials

Transgene Biotek Technicals

EMA & SMA

Current Price
₹2.99
+ 0.27 (9.93%)
pointer
  • Bearish Moving Average 14
  • Bullish Moving Average 2
  • 20 Day
  • ₹3.26
  • 50 Day
  • ₹3.60
  • 100 Day
  • ₹3.88
  • 200 Day
  • ₹4.34

Resistance and Support

2.84 Pivot Speed
  • R3 3.34
  • R2 3.16
  • R1 3.02
  • S1 2.70
  • S2 2.52
  • S3 2.38

Transgene Biotek Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-11-14 Quarterly Results
2025-08-07 Quarterly Results
2025-05-07 Audited Results
2025-01-24 Quarterly Results
2024-11-12 Quarterly Results & A.G.M.

Transgene Biotek F&O

Transgene Biotek Shareholding Pattern

23.64%
71.86%
4.5%

About Transgene Biotek

  • NSE Symbol
  • TRABI
  • BSE Symbol
  • 526139
  • Chairman & Managing Director
  • Dr. K Koteswara Rao
  • ISIN
  • INE773D01018

Similar Stocks to Transgene Biotek

Transgene Biotek FAQs

Transgene Biotek share price is ₹2 As on 12 December, 2025 | 19:07

The Market Cap of Transgene Biotek is ₹22.7 Cr As on 12 December, 2025 | 19:07

The P/E ratio of Transgene Biotek is -14 As on 12 December, 2025 | 19:07

The PB ratio of Transgene Biotek is 2.1 As on 12 December, 2025 | 19:07

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23